Signature Ajuokenya image

Haemophilus influenzae type b

Combinations ;

1. Haemophilus B conj vaccine/Adsorbed DPT

2. Haemophilus B conj vaccine/Adsorbed DPT/Inactivated Polio

3. Haemophilus B conj to Tetanus Protein

Haemophilus Influenza Type B Vaccine Brands
Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
ACT HiB Sanofi Ltd. 1 dose vial KES 1,238
Haemophilus Influenza Type B Vaccine More info
Mode Of Action

excite immune system to produce antibodies corresponding to the vaccine antigen
Drug Indication Immunization of children 6wks to 5yrs against invasive diseases caused by haemophilus influenza type B especially meningitis.
Precautions Allergic reactions, acute infection, febrile illness (delay use).
Side Effects Allergic reactions, headache, malaise, Guillain-Barre Syndrome, fever
Dosage Children aged 6wks: at 6th, 10th and 14th wks. Children aged 6-12months: one injection monthly for 2 consecutive months and booster dose 12 months later. Children aged 1-5yrs: one injection.
Drug Category DRUGS ACTING ON INFECTIONS
Drug Sub-Category Vaccines

1. Haemophilus B conj vaccine/Adsorbed DPT

Dose ; 6, 10, 14 weeks

Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Actacel Sanofi Ltd. 1 dose syringe KES 2,718

2. Haemophilus B conj vaccine/Adsorbed DPT/Inactivated Polio

Dosage ; 6th, 10th and 14th wks, Booster at 12-18 months

Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Tetract HiB Sanofi Ltd. 1 dose syringe KES 2,262

3. Haemophilus B conj to Tetanus Protein

Contraindication; Active infection

2-12 month old; 3 injections 0.5ml each at 4 weeks interval then booster at second year of life

Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Hiberix GSK Ltd. 1 dose syringe KES 882